Addictions, Drug & Alcohol Institute

ADAI Publications

32 publications found

  1. Iacobelli NP, Estrella L, Owens MD, Bhatraju EP, Gojic AJ, Kennedy D, Chander G, Tsui JI. “You’re doing it because your freedom is on the line”: a qualitative study exploring how people who use opioids and methamphetamine navigate legal involvement and carceral treatment for substance use disorder. Harm Reduction Journal 2026; 23, 30. [doi: 10.1186/s12954-025-01378-7] PMID: 41547813
  2. Janson S, Newman A, Banta-Green CJ, Glick SN, Tinsley J, Owens MD. Substance use treatment utilization and unmet demand among recently incarcerated syringe services program participants in Washington state. Harm Reduction Journal 2026 (in press). [doi: 10.1186/s12954-026-01512-z]
  3. ADAI, Research with Expert Advisors on Drug Use (READU), Owens M. The Community-Law Enforcement Aligning in Response to Substance use (CLEARS) Project. Summary of Process Evaluation Findings. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, June 2025, 28 p.
  4. Siebert SL, Owens MD, Folk JB, Moore KE. Criminal justice staff’s professional quality of life and interactions with justice-involved individuals: The moderating role of stigma. Deviant Behavior 2025;46(6):803-819. [doi: 10.1080/01639625.2024.2372419] PMID: 40519513
  5. Owens MD, Adwell A, Singh S, Osilla K, Tweedy M, Tsui J. “All I want is the best for my brother”: Interest in a Community Reinforcement and Family Training (CRAFT)-based group intervention among concerned significant others of individuals on office-based medications for opioid use disorder. BMC Psychiatry 2025;25:748. [doi: 10.1186/s12888-025-07132-4] PMID: 40745287 PMCID: PMC12312360
  6. Owens MD, McKee M, Rickert C, Rogel B, Starnes B. Development and exploratory evaluation of substance use and substance use disorder training for the Washington State Basic Law Enforcement Academy. Policing 2024;18:paae091. [doi: 10.1093/police/paae091]
  7. Banta-Green CJ, Owens MD, Williams JR, Floyd AS, Williams-Gilbert W, Kingston S. Community-based medications first for opioid use disorder – Care utilization and mortality outcomes. Substance Abuse and Rehabilitation 2024;15:173-183 [doi: 10.2147/sar.s475807]
  8. Owens MD, Banta-Green CJ, Newman A, Marren R, Takushi R. Insights into a recovery community center model: Results from qualitative interviews with staff and member facilitators from Recovery Cafe in Seattle, Washington. Alcoholism Treatment Quarterly 2023; 41(1):62-75. [doi: 10.1080/07347324.2022.2088323]
  9. ADAI, Research with Expert Advisors on Drug Use (READU) Team, Owens M. Summary of Findings – Policy Codesign to Improve Interactions Between Law Enforcementa and People Who Use Drugs. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, June 2023, 21 p.
  10. Peavy KM, Adwell A, Owens MD, Banta-Green CJ. Perspectives on medication treatment for opioid use disorder in adolescents: Results from a provider learning series. Substance Use & Misuse 2023;58(1):160-162. [doi: 10.1080/10826084.2022.2136493] PMID: 36371698
  11. Owens M, Borges A, McGrath J, Stern MF. The Status of Medications for Opioid Use Disorder (MOUD) Provision in Washington State Jails, 2021. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, May 2023
  12. Banta-Green CJ, Owens MD, Williams JR, Sears JM, Floyd AS, Williams-Gilbert W, Kingston S. Community Based Medications First for Opioid Use Disorder – Care Utilization and Mortality Outcomes. Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Denver, CO, June 2023
  13. Moore KE, Siebert SL, Kromash R, Owens MD, Allen D. Negative attitudes about medications for opioid use disorder among criminal legal staff. Drug and Alcohol Dependence Rep 2022;3:100056. [doi: 10.1016/j.dadr.2022.100056] PMID: 36845981 PMCID: PMC9948914
  14. Banta-Green CJ, Owens MD, Williams JR, Sears JM, Floyd AS, Williams-Gilbert W, Kingston S. The Community-Based Medication-First program for opioid use disorder: a hybrid implementation study protocol of a rapid access to buprenorphine program in Washington State. Addiction Science & Clinical Practice 2022;17:34. [doi: 10.1186/s13722-022-00315-4] PMID: 35799210 PMCID: PMC9261214
  15. Owens MD, Ngo S, Grinnell S, Pearlman D, Bekemeier B, Cusworth Walker S. Co-producing evidence-informed criminal legal re-entry policy with the community: an application of policy codesign. Evidence & Policy 2022;18(2):356-375. [doi: 10.1332/174426421X16445109542161]
  16. Peavy KM, Banta-Green C, Owens M. Opioids and Stimulants: What Are They and How Are People Using Them? Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, April 2021
  17. Peavy KM, Banta-Green C, Owens M. Helping People Who Use Opioids and Stimulants. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, April 2021
  18. Finlay AK, Owens MD, Taylor E, Nash A, Capdarest-Arest N, Rosenthal J, Blue-Howells J, Clark S, Timko C. A scoping review of military veterans involved in the criminal justice system and their health and healthcare. Health & Justice 2019;7(1):6. [doi: 10.1186/s40352-019-0086-9] PMID: 30963311 PMCID: PMC6718001
  19. McCrady BS, Tonigan JS, Ladd BO, Hallgren KA, Pearson MR, Owens MD, Epstein EE. Alcohol Behavioral Couple Therapy: in-session behavior, active ingredients and mechanisms of behavior change. Journal of Substance Abuse Treatment 2019;99:139-148. [doi: 10.1016/j.jsat.2019.01.018] PMID: 30797386 PMCID: PMC6478165
  20. Owens MD, Kirouac M, Hagler K, Rowell LN, Williams EC. “Being able to speak”: What individuals in jail perceived as helpful about participating in alcohol-related brief interventions. Substance Abuse 2018;39(3):342-347. [doi: 10.1080/08897077.2017.1393034] PMID: 29043918 PMCID: PMC6113115